Description: Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.
Home Page: www.bayer.com
Kaiser-Wilhelm-Allee 1
Leverkusen,
51368
Germany
Phone:
49 214 30 1
Officers
| Name | Title |
|---|---|
| Mr. Werner Baumann | Chairman of Management Board, CEO & Chief Sustainability Officer |
| Mr. Wolfgang U. Nickl | CFO & Member of Management Board |
| Mr. Heiko W. J. Schipper | Member of Management Board & Pres of the Consumer Health Division |
| Mr. Stefan Oelrich | Head of the Pharmaceuticals Division & Member of the Board of Management |
| Ms. Sarena S. Lin | Chief Transformation & Talent Officer, Labor Director and Member of Management Board |
| Mr. Rodrigo Santos | Member of Management Board & Pres of the Crop Science Division |
| Mr. Bernd-Peter Bier | Head of Accounting and Head of Taxes |
| Mr. Oliver Maier | Head of Investor Relations |
| Dr. Gabriel Harnier | Head of Law, Patents & Compliance |
| Mr. Michael Preuss | Head of Communications, Gov. Relations and Corp. Brand |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 6.5833 |
|---|---|
| Trailing PE: | 13.1261 |
| Price-to-Book MRQ: | 1.3592 |
| Price-to-Sales TTM: | 1.0195 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 102296 |